@misc{indiciae598faafd5d74,
  title = {Targeting ALC1 can safely expand the therapeutic utility of PARP inhibitors across high-grade serous ovarian cancers},
  author = {Verma, P. and Aubuchon, L. N. and Wong, D. H. and Ramakrishnan, N. M. and Reddy, R. and Compadre, A. and Lomonosova, E. and Jackson, K. E. and Kemper, D. and Mehta, V. and Zoberi, K. and Khabele, D. and Christie, E. L. and Mullen, M. M.},
  year = {2025},
  doi = {10.64898/2025.12.04.692458},
  url = {https://www.biorxiv.org/content/10.64898/2025.12.04.692458v1},
  note = {Source identifier: 10.64898/2025.12.04.692458}
}